Literature DB >> 27045475

Hepatocellular carcinoma: Mouse models and the potential roles of proteases.

James M Henderson1, Hui Emma Zhang1, Natasa Polak1, Mark D Gorrell2.   

Abstract

Primary liver cancer is the second most common cause of mortality from cancer. The most common models of hepatocellular carcinoma, which use a chemical and/or metabolic insult, xenograft, or genetic manipulation, are discussed in this review. In the tumour microenvironment lymphocytes, fibroblasts, endothelial cells and antigen presenting cells are important determinants of cell fate. These cells make a range of proteases that modify the biological activity of other proteins, particularly extracellular matrix proteins that alter cell migration of tumour cells, fibroblasts and leucocytes, and chemokines that alter leucocyte migration. The DPP4 family of post-proline peptidase enzymes modifies cell movement and the activities of many bioactive molecules including growth factors and chemokines.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dipeptidyl peptidase; Fibroblast activation protein; Hepatocellular carcinoma; Mouse models

Mesh:

Substances:

Year:  2016        PMID: 27045475     DOI: 10.1016/j.canlet.2016.03.047

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

Review 1.  Animal models of cholangiocarcinoma.

Authors:  Emilien Loeuillard; Samantha R Fischbach; Gregory J Gores; Sumera Rizvi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-05       Impact factor: 5.187

2.  Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs.

Authors:  Lukáš Tenora; Jesse Alt; Ranjeet P Dash; Alexandra J Gadiano; Kateřina Novotná; Vijayabhaskar Veeravalli; Jenny Lam; Quinn R Kirkpatrick; Kathryn M Lemberg; Pavel Majer; Rana Rais; Barbara S Slusher
Journal:  J Med Chem       Date:  2019-03-29       Impact factor: 7.446

Review 3.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Robin Kate Kelley; Augusto Villanueva; Amit G Singal; Eli Pikarsky; Sasan Roayaie; Riccardo Lencioni; Kazuhiko Koike; Jessica Zucman-Rossi; Richard S Finn
Journal:  Nat Rev Dis Primers       Date:  2021-01-21       Impact factor: 52.329

4.  Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma.

Authors:  James M Henderson; Natasa Polak; Jinbiao Chen; Ben Roediger; Wolfgang Weninger; James G Kench; Geoffrey W McCaughan; Hui Emma Zhang; Mark D Gorrell
Journal:  Sci Rep       Date:  2018-07-06       Impact factor: 4.379

Review 5.  Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models.

Authors:  Qilong Wang; Ping Zhang; Zhongmin Li; Xiangru Feng; Chengyue Lv; Huaiyu Zhang; Haihua Xiao; Jianxun Ding; Xuesi Chen
Journal:  Theranostics       Date:  2019-02-20       Impact factor: 11.556

6.  A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.

Authors:  Azra Memon; Yuliya Pyao; Yerin Jung; Jung Il Lee; Woon Kyu Lee
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.